Cover Story
FreeHealth Equity
By Matthew Bin Han Ong
A recent analysis of the National Cancer Institute’s workforce and grant recipients shows that Black and Hispanic scientists are dramatically underrepresented across key metrics, both intramural and extramural.
In Brief
Clinical Roundup
Drugs & Targets
NCI Trials
NCI Trials for July 2021
The National Cancer Institute approved the following clinical research studies last month. For further information, contact the principal investigator listed.
Trending Stories
- FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- Beyond the $500B Stargate Project: The frontier of AI in oncology beckons
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Tracking Trump’s early impact on cancer policy
Research and care disrupted, NCI programs face unpredictable future - Felix Feng, GU cancer researcher who made fundamental discoveries in genomics, dies at 48
- Trump 2016: A look back at the 45th president’s impact on oncology